Cargando…

Designing isolation guidelines for COVID-19 patients with rapid antigen tests

Appropriate isolation guidelines for COVID-19 patients are warranted. Currently, isolating for fixed time is adopted in most countries. However, given the variability in viral dynamics between patients, some patients may no longer be infectious by the end of isolation, whereas others may still be in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Yong Dam, Ejima, Keisuke, Kim, Kwang Su, Joohyeon, Woo, Iwanami, Shoya, Fujita, Yasuhisa, Jung, Il Hyo, Aihara, Kazuyuki, Shibuya, Kenji, Iwami, Shingo, Bento, Ana I., Ajelli, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392070/ https://www.ncbi.nlm.nih.gov/pubmed/35987759 http://dx.doi.org/10.1038/s41467-022-32663-9

Ejemplares similares

Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models
por: Jeong, Yong Dam, et al.
Publicado: (2022)

Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study
por: Ejima, Keisuke, et al.
Publicado: (2022)

Revisiting the guidelines for ending isolation for COVID-19 patients
por: Jeong, Yong Dam, et al.
Publicado: (2021)

Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model
por: Ejima, Keisuke, et al.
Publicado: (2021)

Estimation of the incubation period of COVID-19 using viral load data
por: Ejima, Keisuke, et al.
Publicado: (2021)

Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection
por: Kim, Kwang Su, et al.
Publicado: (2021)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2
por: Kim, Kwang Su, et al.
Publicado: (2021)

Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
por: Tatematsu, Daiki, et al.
Publicado: (2023)

Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
por: Iwanami, Shoya, et al.
Publicado: (2021)

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir
por: Torii, Shiho, et al.
Publicado: (2023)

A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture
por: Iwanami, Shoya, et al.
Publicado: (2017)

Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution
por: Sunagawa, Junya, et al.
Publicado: (2023)

Modeling the obesity epidemic: social contagion and its implications for control
por: Ejima, Keisuke, et al.
Publicado: (2013)

The Impact of Model Building on the Transmission Dynamics under Vaccination: Observable (Symptom-Based) versus Unobservable (Contagiousness-Dependent) Approaches
por: Ejima, Keisuke, et al.
Publicado: (2013)

Probabilistic differential diagnosis of Middle East respiratory syndrome (MERS) using the time from immigration to illness onset among imported cases
por: Ejima, Keisuke, et al.
Publicado: (2014)

Real-time Investigation of Measles Epidemics with Estimate of Vaccine Efficacy
por: Ejima, Keisuke, et al.
Publicado: (2012)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

The Time Required to Estimate the Case Fatality Ratio of Influenza Using Only the Tip of an Iceberg: Joint Estimation of the Virulence and the Transmission Potential
por: Ejima, Keisuke, et al.
Publicado: (2012)

Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation for analyzing extracellular viral markers
por: Kitagawa, Kosaku, et al.
Publicado: (2023)

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
por: Ohashi, Hirofumi, et al.
Publicado: (2022)

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection
por: Kumata, Ryuichi, et al.
Publicado: (2022)

Identifying viral parameters from in vitro cell cultures
por: Iwami, Shingo, et al.
Publicado: (2012)

Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey
por: Yoshida, Makoto, et al.
Publicado: (2022)

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma
por: Iwanami, Shoya, et al.
Publicado: (2020)

Number of infection events per cell during HIV-1 cell-free infection
por: Ito, Yusuke, et al.
Publicado: (2017)

Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan
por: Yamamoto, Nao, et al.
Publicado: (2022)

Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell Culture
por: Ikeda, Hiroki, et al.
Publicado: (2015)

Corrigendum: Quantifying the Antiviral Effect of IFN on HIV-1 Replication in Cell Culture
por: Ikeda, Hiroki, et al.
Publicado: (2015)

Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model
por: Ikeda, Hiroki, et al.
Publicado: (2014)

HIV-1 Vpr Accelerates Viral Replication during Acute Infection by Exploitation of Proliferating CD4(+) T Cells In Vivo
por: Sato, Kei, et al.
Publicado: (2013)

A method to determine the duration of the eclipse phase for in vitro infection with a highly pathogenic SHIV strain
por: Kakizoe, Yusuke, et al.
Publicado: (2015)

Quantifying the effect of Vpu on the promotion of HIV-1 replication in the humanized mouse model
por: Ikeda, Hiroki, et al.
Publicado: (2016)

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021)

Cell-to-cell infection by HIV contributes over half of virus infection
por: Iwami, Shingo, et al.
Publicado: (2015)

Experimental and theoretical bases for mechanisms of antigen discrimination by T cells
por: Kajita, Masashi K., et al.
Publicado: (2015)

Evaluating the impact of test-trace-isolate for COVID-19 management and alternative strategies
por: Zhang, Kun, et al.
Publicado: (2023)

Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin
por: Iwami, Shingo, et al.
Publicado: (2015)

How to interpret the transmissibility of novel influenza A(H7N9): an analysis of initial epidemiological data of human cases from China
por: Nishiura, Hiroshi, et al.
Publicado: (2013)

Missing information in animal surveillance of MERS-CoV
por: Nishiura, Hiroshi, et al.
Publicado: (2014)

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments
por: Akazawa, Daisuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dslfkg5dfhojug58treimdolrk